Differences in interferon sensitivity and biological properties of two related isolates of simian virus 5: A model for virus persistence

Virology

Volumn 293, Issue 2, 2002, Pages 234-242

  Chatziandreou, N ^a   Young, D ^a   Andrejeva, J ^a   Goodbourn, S ^b   Randall, R E ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; NUCLEOCAPSID PROTEIN; STAT1 PROTEIN; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL INCLUSION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOG; EMBRYO; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN LOCALIZATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SIMIAN VIRUS;

CANIS FAMILIARIS; SIMIAE; SIMIAN PARAINFLUENZA VIRUS 5;

EID: 0036058105     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1302     Document Type: Article

References (42)

1. Epidemiologic studies of latent virus infections in captive monkeys and baboons. II. Serologic evidence of myxovirus infections with special reference to SV5
2. In vitro identification and characterization of a virus isolated from a dog with neurological dysfunction
3. Acute encephalitis and hydrocephalus in dogs caused by canine parainfluenza virus
4. Persistent infection of Vero cells by paramyxoviruses. A morphological and immunoelectron microscopic investigation
5. In vitro cytopathogenicity and in vivo virulence of two strains of canine parainfluenza virus
6. Multiplication of a myxovirus (SV5) with minimal cytopathic effects and without interference
7. Sendai virus and simian virus 5 block activation of interferon-responsive genes: Importance for virus pathogenesis
8. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation
9. Isolation of a paramyxovirus from the cerebrospinal fluid of a dog with posterior paresis
10. Evidence that the paramyxovirus SV5 can establish quiescent infections by remaining inactive in cytoplasmic inclusion bodies
11. Sendai virus C proteins must interact directly with cellular components to interfere with interferon action
12. Interferons: Cell signalling, immune modulation, antiviral responses and virus countermeasures
13. Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-alpha/beta-mediated responses
14. Recent advances in the study of simian viruses
15. Parainfluenza-5 virus. Infection of man and animals
16. Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis
17. Recovery of infectious human parainfluenza virus type 2 from cDNA clones and properties of the defective virus without V-specific cysteine-rich domain
18. STAT1 is inactivated by a caspase
19. Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription
20. C terminal Cys-rich region of mumps virus structural V protein correlates with block of interferon alpha and gamma signal transduction pathway through decrease of STAT 1-alpha
21. Paramyxoviridae: The viruses and their replication
22. The virus battles: IFN induction of the antiviral state and the mechanisms of viral evasion
23. The paramyxovirus simian virus 5 V protein slows progression of the cell cycle
24. The V protein of the paramyxovirus SV5 interacts with damage-specific DNA binding protein
25. Cyclic-AMP response-binding protein and the catalytic subunit of protein kinase A are present in F9 embryonal carcinoma cells but are unable to activate the somatostatin promoter
26. Persistent parainfluenza virus shedding during isolation at the South Pole
27. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilising signal transducer and activator of transcription 2
28. Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway
29. Inducible expression of the P, V and NP genes of the paramyxovirus SV5 in cell-lines and an examination of NP:P and NP:V interactions
30. NP:P and NP:V interactions of the paramyxovirus simian virus 5 examined using a novel protein: Protein capture assay
31. Intranuclear localisation of herpes simplex virus immediate-early and delayed-early proteins. Evidence that ICP4 is associated with progeny virus DNA
32. Paramyxovirus persistence, consequences for host and virus
33. Isolation and characterisation of monoclonal antibodies to simian virus 5 and their use in revealing antigenic differences between human, canine and simian isolates
34. Specific molecular activities of recombinant and hybrid interferons
35. Two nontemplated nucleotide additions are required to generate the P mRNA of parainfluenza type 2 since the RNA genome encodes protein V
36. How cells respond to interferons
37. Sendai virus C protein physically associates with Stat1
38. Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5
39. An investigation of the incidence, epidemiology and control of simian virus 5
40. Isolation of highly fusogenic variants of simian virus 5 from persistently infected cells that produce and respond to interferon
41. Paramyxoviruses utilize different molecular mechanisms to circumvent the interferon response
42. A single amino acid substitution in the V protein of SV5 differentiates its ability to block IFN signalling in human and murine cells